Literature DB >> 17959291

Withania somnifera: an Indian ginseng.

S K Kulkarni1, Ashish Dhir.   

Abstract

Withania somnifera, popularly known as Ashwagandha is widely considered as the Indian ginseng. In Ayurveda, it is classified as a rasayana (rejuvenation) and expected to promote physical and mental health, rejuvenate the body in debilitated conditions and increase longevity. Having wide range of activity, it is used to treat almost all disorders that affect the human health. The present review discusses the pharmacological basis of the use of W. somnifera in various central nervous system (CNS) disorders, particularly its indication in epilepsy, stress and neurodegenerative diseases such as Parkinson's and Alzheimer's disorders, tardive dyskinesia, cerebral ischemia, and even in the management of drug addiction.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17959291     DOI: 10.1016/j.pnpbp.2007.09.011

Source DB:  PubMed          Journal:  Prog Neuropsychopharmacol Biol Psychiatry        ISSN: 0278-5846            Impact factor:   5.067


  70 in total

1.  Withania somnifera reverses Alzheimer's disease pathology by enhancing low-density lipoprotein receptor-related protein in liver.

Authors:  Neha Sehgal; Alok Gupta; Rupanagudi Khader Valli; Shanker Datt Joshi; Jessica T Mills; Edith Hamel; Pankaj Khanna; Subhash Chand Jain; Suman S Thakur; Vijayalakshmi Ravindranath
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-30       Impact factor: 11.205

2.  Withania somnifera prevents morphine withdrawal-induced decrease in spine density in nucleus accumbens shell of rats: a confocal laser scanning microscopy study.

Authors:  Sanjay Kasture; Stefania Vinci; Federico Ibba; Alessandro Puddu; Mara Marongiu; Balasubramanian Murali; Augusta Pisanu; Daniele Lecca; Gerald Zernig; Elio Acquas
Journal:  Neurotox Res       Date:  2009-06-24       Impact factor: 3.911

Review 3.  Plant-based Rasayana drugs from Ayurveda.

Authors:  Subramani Paranthaman Balasubramani; Padma Venkatasubramanian; Subrahmanya Kumar Kukkupuni; Bhushan Patwardhan
Journal:  Chin J Integr Med       Date:  2011-03-09       Impact factor: 1.978

Review 4.  Middle East Medicinal Plants in the Treatment of Diabetes: A Review.

Authors:  Alaa M Abu-Odeh; Wamidh H Talib
Journal:  Molecules       Date:  2021-01-31       Impact factor: 4.411

5.  Neuroprotective role of Withania somnifera root extract in maneb-paraquat induced mouse model of parkinsonism.

Authors:  Jay Prakash; Satyndra Kumar Yadav; Shikha Chouhan; Surya Pratap Singh
Journal:  Neurochem Res       Date:  2013-02-22       Impact factor: 3.996

6.  Probing of metabolites in finely powdered plant material by direct laser desorption ionization mass spectrometry.

Authors:  Syed Ghulam Musharraf; Arslan Ali; M Iqbal Choudhary
Journal:  J Am Soc Mass Spectrom       Date:  2014-02-05       Impact factor: 3.109

7.  Standardized extract of Withania somnifera (Ashwagandha) markedly offsets rotenone-induced locomotor deficits, oxidative impairments and neurotoxicity in Drosophila melanogaster.

Authors:  M J Manjunath
Journal:  J Food Sci Technol       Date:  2013-12-01       Impact factor: 2.701

8.  WsSGTL1 gene from Withania somnifera, modulates glycosylation profile, antioxidant system and confers biotic and salt stress tolerance in transgenic tobacco.

Authors:  Vibha Pandey; Abhishek Niranjan; Neelam Atri; K Chandrashekhar; Manoj K Mishra; Prabodh K Trivedi; Pratibha Misra
Journal:  Planta       Date:  2014-03-08       Impact factor: 4.116

9.  Oxidative stress induced NMDA receptor alteration leads to spatial memory deficits in temporal lobe epilepsy: ameliorative effects of Withania somnifera and Withanolide A.

Authors:  Smijin Soman; P K Korah; S Jayanarayanan; Jobin Mathew; C S Paulose
Journal:  Neurochem Res       Date:  2012-06-15       Impact factor: 3.996

10.  Withania somnifera and Its Withanolides Attenuate Oxidative and Inflammatory Responses and Up-Regulate Antioxidant Responses in BV-2 Microglial Cells.

Authors:  Grace Y Sun; Runting Li; Jiankun Cui; Mark Hannink; Zezong Gu; Kevin L Fritsche; Dennis B Lubahn; Agnes Simonyi
Journal:  Neuromolecular Med       Date:  2016-05-21       Impact factor: 3.843

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.